Showing 1 - 19 results of 19 for search 'Filippo Montemurro', query time: 0.14s
Refine Results
-
1
-
2
-
3
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives by Elisa Agostinetto, Filippo Montemurro, Fabio Puglisi, Carmen Criscitiello, Giampaolo Bianchini, Lucia Del Mastro, Martino Introna, Carlo Tondini, Armando Santoro, Alberto Zambelli
Published 2022-04-01
Article -
4
-
5
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report by Silvia Benvenuti, Melissa Milan, Elena Geuna, Alberto Pisacane, Rebecca Senetta, Gennaro Gambardella, Giulia M Stella, Filippo Montemurro, Anna Sapino, Carla Boccaccio, Paolo M Comoglio
Published 2020-07-01
Article -
6
The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients by Enrico Berrino, Umberto Miglio, Sara Erika Bellomo, Carla Debernardi, Alberto Bragoni, Annalisa Petrelli, Eliano Cascardi, Silvia Giordano, Filippo Montemurro, Caterina Marchiò, Tiziana Venesio, Anna Sapino
Published 2022-06-01
Article -
7
Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study by Elena Geuna, Pasquale Lombardi, Rossella Martinello, Davide Garino, Alessandro Bonzano, Danilo Galizia, Annamaria Nuzzo, Paola Berchialla, Paolo Becco, Monica Mangioni, Lorena De Zarlo, Filippo Montemurro
Published 2020-01-01
Article -
8
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests by Mariarosaria Saponaro, Luigi Annunziata, Antonella Turla, Ilaria Viganò, Michele De Laurentiis, Mario Giuliano, Lucia Del Mastro, Filippo Montemurro, Fabio Puglisi, Carmine De Angelis, Giuseppe Buono, Francesco Schettini, Grazia Arpino
Published 2022-11-01
Article -
9
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2... by Valentina Rossi, Paola Berchialla, Diana Giannarelli, Cecilia Nisticò, Gianluigi Ferretti, Simona Gasparro, Michelangelo Russillo, Giovanna Catania, Leonardo Vigna, Rossella Letizia Mancusi, Emilio Bria, Filippo Montemurro, Francesco Cognetti, Alessandra Fabi
Published 2019-10-01
Article -
10
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations by Andrea D’Arienzo, Annarita Verrazzo, Martina Pagliuca, Fabiana Napolitano, Sara Parola, Martina Viggiani, Roberta Caputo, Fabio Puglisi, Mario Giuliano, Lucia Del Mastro, Grazia Arpino, Michelino De Laurentiis, Filippo Montemurro
Published 2023-08-01
Article -
11
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Developmen... by Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, Filippo Montemurro, Laura Biganzoli, Laura Cortesi, Alberto Zambelli, Carmen Criscitiello, Alessia Levaggi, Benedetta Conte, Massimo Calabrese, Alba Fiorentino, Caterina Marchiò, Corrado Tinterri, Veronica Andrea Fittipaldo, Giovanni Pappagallo, Stefania Gori
Published 2019-08-01
Article -
12
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas by Enrico Berrino, Laura Annaratone, Sara Erika Bellomo, Giulio Ferrero, Amedeo Gagliardi, Alberto Bragoni, Dora Grassini, Simonetta Guarrera, Caterina Parlato, Laura Casorzo, Mara Panero, Ivana Sarotto, Silvia Giordano, Matteo Cereda, Filippo Montemurro, Riccardo Ponzone, Nicola Crosetto, Alessio Naccarati, Anna Sapino, Caterina Marchiò
Published 2022-08-01
Article -
13
Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients by Federica Miglietta, Letizia Pontolillo, Carmine De Angelis, Roberta Caputo, Monica Marino, Emilio Bria, Rossana Di Rienzo, Annarita Verrazzo, Carlo Buonerba, Giampaolo Tortora, Giuseppe Di Lorenzo, Lucia Del Mastro, Mario Giuliano, Filippo Montemurro, Fabio Puglisi, Valentina Guarneri, Michelino De Laurentiis, Luca Scafuri, Grazia Arpino
Published 2024-06-01
Article -
14
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer by Fabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, Marcello Ceppi, Luca Boni, Filippo Montemurro, Stefania Russo, Claudia Bighin, Michelino De Laurentiis, Mario Giuliano, Giancarlo Bisagni, Antonio Durando, Anna Turletti, Ornella Garrone, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Adriano Gravina, Sabino De Placido, Francesco Cognetti, Lucia Del Mastro
Published 2021-06-01
Article -
15
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer by Luca Licata, Giulia Viale, Mario Giuliano, Giuseppe Curigliano, Mariana Chavez-MacGregor, Julia Foldi, Oluchi Oke, Joseph Collins, Lucia Del Mastro, Fabio Puglisi, Filippo Montemurro, Claudio Vernieri, Lorenzo Gerratana, Sara Giordano, Alessia Rognone, Lorenzo Sica, Oreste Davide Gentilini, Stefano Cascinu, Lajos Pusztai, Antonio Giordano, Carmen Criscitiello, Giampaolo Bianchini
Published 2023-06-01
Article -
16
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or... by Benedetta Pellegrino, Luisa Carbognin, Emilio Bria, Alberto Zambelli, Filippo Montemurro, Elena Fiorio, Claudio Zamagni, Nicoletta Campanini, Michele Tognetto, Gabriele Missale, Antonino Musolino, Stefania Gori, Giuseppe Maglietta, Chiara Tommasi, Olga Serra, Elisabetta Cretella, Massimo Ambroggi, Antonio Frassoldati, Giancarlo Bisagni, Chiara Casarini, Antonella Mura, Lorenzo Gianni, Renata Todeschini, Enrico Maria Silini
Published 2023-11-01
Article -
17
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach by Alessandra Fabi, Giuseppe Buono, Emilio Bria, Giampaolo Bianchini, Giuseppe Curigliano, Giuseppe Curigliano, Michelino De Laurentiis, Sabino De Placido, Lucia Del Mastro, Lucia Del Mastro, Valentina Guarneri, Daniele Generali, Lorenzo Livi, Lorenzo Livi, Vito Lorusso, Filippo Montemurro, Fabio Puglisi, Fabio Puglisi, Paolo Vigneri, Paolo Vigneri, Alberto Zambelli, Alberto Zambelli, Grazia Arpino
Published 2022-09-01
Article -
18
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study by Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, Maddalena Barba, Laura Pizzuti, Lorena Filomeno, Cristiana Ercolani, Nicola Tinari, Antonino Grassadonia, Daniele Santini, Mauro Minelli, Filippo Montemurro, Maria Agnese Fabbri, Marco Mazzotta, Teresa Gamucci, Giuliana D’Auria, Claudio Botti, Fabio Pelle, Flavia Cavicchi, Sonia Cappelli, Federico Cappuzzo, Giuseppe Sanguineti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Marcello Maugeri-Saccà, Ruggero De Maria, Gennaro Ciliberto, Francesca Sperati, Patrizia Vici
Published 2022-10-01
Article -
19
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study by Marina Elena Cazzaniga, Paolo Pronzato, Domenico Amoroso, Antonio Bernardo, Laura Biganzoli, Giancarlo Bisagni, Livio Blasi, Emilio Bria, Francesco Cognetti, Lucio Crinò, Michelino De Laurentiis, Lucia Del Mastro, Sabino De Placido, Alessandra Beano, Francesco Ferraù, Silva Foladore, Rosachiara Forcignanò, Teresa Gamucci, Ornella Garrone, Alessandra Gennari, Monica Giordano, Francesco Giotta, Filippo Giovanardi, Luciano Latini, Lorenzo Livi, Paolo Marchetti, Rodolfo Mattioli, Andrea Michelotti, Filippo Montemurro, Carlo Putzu, Ferdinando Riccardi, Giuseppina Ricciardi, Emanuela Romagnoli, Giuseppina Sarobba, Simon Spazzapan, Pierosandro Tagliaferri, Nicola Tinari, Giuseppe Tonini, Anna Turletti, Claudio Verusio, Alberto Zambelli, Giorgio Mustacchi
Published 2023-12-01
Article